200 related articles for article (PubMed ID: 3346076)
41. Antigen conformation dependence of Chlamydia trachomatis infectivity neutralization.
Fan J; Stephens RS
J Infect Dis; 1997 Sep; 176(3):713-21. PubMed ID: 9291320
[TBL] [Abstract][Full Text] [Related]
42. Reactions of polyclonal and neutralizing anti-p54 monoclonal antibodies with an isolated, species-specific 54-kilodalton protein of Chlamydia pneumoniae.
Wiedmann-Al-Ahmad M; Schuessler P; Freidank HM
Clin Diagn Lab Immunol; 1997 Nov; 4(6):700-4. PubMed ID: 9384292
[TBL] [Abstract][Full Text] [Related]
43. Neutralization of Chlamydia trachomatis cell culture infection by serovar-specific monoclonal antibodies.
Lucero ME; Kuo CC
Infect Immun; 1985 Nov; 50(2):595-7. PubMed ID: 4055037
[TBL] [Abstract][Full Text] [Related]
44. Discovery of Human-Specific Immunodominant
Rahman KS; Darville T; Russell AN; O'Connell CM; Wiesenfeld HC; Hillier SL; Chowdhury EU; Juan YC; Kaltenboeck B
mSphere; 2018 Aug; 3(4):. PubMed ID: 30068558
[No Abstract] [Full Text] [Related]
45. [The immunochemical and biological properties of monoclonal antibodies to Chlamydia trachomatis].
Kutlin AV; Drobyshevskaia EI; Shatkin AA
Zh Mikrobiol Epidemiol Immunobiol; 1996; (1):3-6. PubMed ID: 8820666
[TBL] [Abstract][Full Text] [Related]
46. Staining characteristics of six commercially available monoclonal immunofluorescence reagents for direct diagnosis of Chlamydia trachomatis infections.
Cles LD; Bruch K; Stamm WE
J Clin Microbiol; 1988 Sep; 26(9):1735-7. PubMed ID: 2460495
[TBL] [Abstract][Full Text] [Related]
47. Differences in susceptibilities of the lymphogranuloma venereum and trachoma biovars of Chlamydia trachomatis to neutralization by immune sera.
Peterson EM; Hoshiko M; Markoff BA; Lauermann MW; de la Maza LM
Infect Immun; 1990 Apr; 58(4):938-43. PubMed ID: 2318536
[TBL] [Abstract][Full Text] [Related]
48. A poliovirus hybrid expressing a neutralization epitope from the major outer membrane protein of Chlamydia trachomatis is highly immunogenic.
Murdin AD; Su H; Manning DS; Klein MH; Parnell MJ; Caldwell HD
Infect Immun; 1993 Oct; 61(10):4406-14. PubMed ID: 7691749
[TBL] [Abstract][Full Text] [Related]
49. Workshop on in vitro neutralization of Chlamydia trachomatis: summary of proceedings.
Byrne GI; Stephens RS; Ada G; Caldwell HD; Su H; Morrison RP; Van der Pol B; Bavoil P; Bobo L; Everson S
J Infect Dis; 1993 Aug; 168(2):415-20. PubMed ID: 8335979
[TBL] [Abstract][Full Text] [Related]
50. Serovar determination of Chlamydia trachomatis isolates by using type-specific monoclonal antibodies.
Newhall WJ; Terho P; Wilde CE; Batteiger BE; Jones RB
J Clin Microbiol; 1986 Feb; 23(2):333-8. PubMed ID: 2422202
[TBL] [Abstract][Full Text] [Related]
51. Immunotyping of Chlamydia trachomatis with monoclonal antibodies.
Wang SP; Kuo CC; Barnes RC; Stephens RS; Grayston JT
J Infect Dis; 1985 Oct; 152(4):791-800. PubMed ID: 4045232
[TBL] [Abstract][Full Text] [Related]
52. Characterization of kinetics and target proteins for binding of human complement component C3 to the surface-exposed outer membrane of Chlamydia trachomatis serovar L2.
Hall RT; Strugnell T; Wu X; Devine DV; Stiver HG
Infect Immun; 1993 May; 61(5):1829-34. PubMed ID: 8478073
[TBL] [Abstract][Full Text] [Related]
53. Identification of immunodominant linear B-cell epitopes within the major outer membrane protein of Chlamydia trachomatis.
Zhu S; Chen J; Zheng M; Gong W; Xue X; Li W; Zhang L
Acta Biochim Biophys Sin (Shanghai); 2010 Nov; 42(11):771-8. PubMed ID: 20923859
[TBL] [Abstract][Full Text] [Related]
54. Production and partial characterization of monoclonal antibodies to four Chlamydia psittaci isolates.
Andersen AA; Van Deusen RA
Infect Immun; 1988 Aug; 56(8):2075-9. PubMed ID: 3294184
[TBL] [Abstract][Full Text] [Related]
55. Analysis of the humoral response elicited in mice by a chimeric peptide representing variable segments I and IV of the major outer membrane protein of Chlamydia trachomatis.
Qu Z; Cheng X; de la Maza LM; Peterson EM
Vaccine; 1994 May; 12(6):557-64. PubMed ID: 7518628
[TBL] [Abstract][Full Text] [Related]
56. Poliovirus hybrids expressing neutralization epitopes from variable domains I and IV of the major outer membrane protein of Chlamydia trachomatis elicit broadly cross-reactive C. trachomatis-neutralizing antibodies.
Murdin AD; Su H; Klein MH; Caldwell HD
Infect Immun; 1995 Mar; 63(3):1116-21. PubMed ID: 7532625
[TBL] [Abstract][Full Text] [Related]
57. Expression of the major outer membrane protein of Chlamydia trachomatis in Escherichia coli.
Manning DS; Stewart SJ
Infect Immun; 1993 Oct; 61(10):4093-8. PubMed ID: 8406797
[TBL] [Abstract][Full Text] [Related]
58. The major outer membrane protein of Chlamydia trachomatis: critical binding site and conformation determine the specificity of antibody binding to viable chlamydiae.
Conlan JW; Kajbaf M; Clarke IN; Chantler S; Ward ME
Mol Microbiol; 1989 Mar; 3(3):311-8. PubMed ID: 2473372
[TBL] [Abstract][Full Text] [Related]
59. Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection.
Cotter TW; Meng Q; Shen ZL; Zhang YX; Su H; Caldwell HD
Infect Immun; 1995 Dec; 63(12):4704-14. PubMed ID: 7591126
[TBL] [Abstract][Full Text] [Related]
60. Protection of wild-type and severe combined immunodeficiency mice against an intranasal challenge by passive immunization with monoclonal antibodies to the Chlamydia trachomatis mouse pneumonitis major outer membrane protein.
Pal S; Bravo J; Peterson EM; de la Maza LM
Infect Immun; 2008 Dec; 76(12):5581-7. PubMed ID: 18809664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
